全文获取类型
收费全文 | 9476篇 |
免费 | 788篇 |
国内免费 | 268篇 |
专业分类
耳鼻咽喉 | 20篇 |
儿科学 | 307篇 |
妇产科学 | 158篇 |
基础医学 | 672篇 |
口腔科学 | 123篇 |
临床医学 | 1629篇 |
内科学 | 1575篇 |
皮肤病学 | 108篇 |
神经病学 | 379篇 |
特种医学 | 262篇 |
外科学 | 621篇 |
综合类 | 2006篇 |
现状与发展 | 1篇 |
预防医学 | 1166篇 |
眼科学 | 120篇 |
药学 | 859篇 |
25篇 | |
中国医学 | 428篇 |
肿瘤学 | 73篇 |
出版年
2024年 | 26篇 |
2023年 | 236篇 |
2022年 | 592篇 |
2021年 | 916篇 |
2020年 | 670篇 |
2019年 | 275篇 |
2018年 | 288篇 |
2017年 | 342篇 |
2016年 | 392篇 |
2015年 | 330篇 |
2014年 | 609篇 |
2013年 | 633篇 |
2012年 | 538篇 |
2011年 | 610篇 |
2010年 | 403篇 |
2009年 | 431篇 |
2008年 | 339篇 |
2007年 | 408篇 |
2006年 | 386篇 |
2005年 | 374篇 |
2004年 | 435篇 |
2003年 | 462篇 |
2002年 | 155篇 |
2001年 | 135篇 |
2000年 | 85篇 |
1999年 | 76篇 |
1998年 | 49篇 |
1997年 | 51篇 |
1996年 | 45篇 |
1995年 | 30篇 |
1994年 | 34篇 |
1993年 | 24篇 |
1992年 | 38篇 |
1991年 | 22篇 |
1990年 | 11篇 |
1989年 | 10篇 |
1988年 | 15篇 |
1987年 | 13篇 |
1986年 | 7篇 |
1985年 | 9篇 |
1984年 | 5篇 |
1983年 | 3篇 |
1982年 | 5篇 |
1981年 | 2篇 |
1980年 | 2篇 |
1979年 | 5篇 |
1976年 | 1篇 |
1973年 | 1篇 |
1972年 | 1篇 |
1906年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
151.
醒脑静联合纳洛酮注射液治疗急性重度酒精中毒疗效观察 总被引:1,自引:0,他引:1
目的:探讨醒脑静与纳洛酮联合应用治疗急性重度酒精中毒的临床疗效.方法:将150例急性重度酒精中毒患者随机分为三组,在常规支持治疗的基础上,A组给予小剂量纳洛酮,B组给予最大剂量纳洛酮,C组给予醒脑静联合最大剂量纳洛酮治疗,对比三组患者完全清醒时间以及药物的不良反应等临床治疗效果.结果:C组患者有效时间、显效时间、痊愈时间、出院时间最短,B组次之,A组时间最长,差异明显(P<0.05),具有统计学意义.C组患者心律失常发生率与B组无明显差异,恶心、呕吐等明显低于A组或B组,差异明显(P<0.05),具有统计学意义.结论:醒脑静联合大剂量纳洛酮治疗急性重度酒精中毒具有更好的临床效果,其酒精中毒症状消失时间进一步缩短,并在呕吐、恶心等并发症的发生上得到了很好的控制,发生率明显降低,值得首选使用. 相似文献
152.
Marie-Ève Boulay Claudia Pruneau-Pomerleau Hélène Villeneuve Francine Deschesnes Lyne Ringuette 《The Journal of asthma》2018,55(3):231-243
Background: A “frequent exacerbator phenotype” has been described, mostly in the population of patients with severe asthma. Further data are needed on such exacerbation-prone patients in milder asthma. Aim: To compare the characteristics of frequent and nonfrequent exacerbators in asthma of different severities and to assess the stability of the exacerbator status. Methods: This was an observational study comparing baseline data from frequent (≥2 exacerbations in the past year) and nonfrequent (<2 exacerbations in the past year) exacerbators. Patients were also followed up for one year. Information regarding clinical, physiologic, and inflammatory characteristics was collected at baseline and one-year follow-up. Results: Forty-seven frequent and 53 nonfrequent exacerbators were recruited. No specific clinical, physiologic, or inflammatory characteristic was observed in the frequent as compared to the nonfrequent exacerbators at baseline. Fifty-eight percent of patients reporting frequent exacerbations at baseline remained in this group after one year of follow-up. Forty-two and 62% of patients with, respectively, mild-to-moderate asthma and severe asthma had frequent exacerbations. In a post hoc analysis according to asthma severity, frequent exacerbators with severe asthma had a higher body mass index and poorer asthma control, although they reported higher adherence to medication, in comparison to frequent exacerbators with mild-to-moderate asthma. No specific characteristics could discriminate between frequent and nonfrequent exacerbators of the same asthma severity. Conclusions: Frequent exacerbators with severe asthma present some specific characteristics not observed in frequent exacerbators with mild-to-moderate disease. However, the latter group should be identified to reassess treatment needs and potential contributing factors. 相似文献
153.
Alison E. Brown Ellen Heinsbroek Meaghan M. Kall Hester Allen Kazim Beebeejaun Paula Blomquist Ines Campos-Matos Colin N.J. Campbell Hamish Mohammed Katy Sinka Theresa Lamagni Nicholas Phin the PHE COVID- Mortality Working Group Gavin Dabrera 《Emerging infectious diseases》2021,27(5):1468
Of the 58,186 coronavirus deaths among adults in England during March–December 2020, 77% occurred in hospitals, 93% were in patients >60 years, and 91% occurred within 28 days of positive specimen. Cumulative mortality rates were highest among persons of Black, Asian, other, or mixed ethnicities and in socioeconomically deprived areas. 相似文献
154.
Hannah A. Bullock Cynthia S. Goldsmith Sherif R. Zaki Roosecelis B. Martines Sara E. Miller 《Emerging infectious diseases》2021,27(4):1023
Efforts to combat the coronavirus disease (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have placed a renewed focus on the use of transmission electron microscopy for identifying coronavirus in tissues. In attempts to attribute pathology of COVID-19 patients directly to tissue damage caused by SARS-CoV-2, investigators have inaccurately reported subcellular structures, including coated vesicles, multivesicular bodies, and vesiculating rough endoplasmic reticulum, as coronavirus particles. We describe morphologic features of coronavirus that distinguish it from subcellular structures, including particle size range (60–140 nm), intracellular particle location within membrane-bound vacuoles, and a nucleocapsid appearing in cross section as dense dots (6–12 nm) within the particles. In addition, although the characteristic spikes of coronaviruses may be visible on the virus surface, especially on extracellular particles, they are less evident in thin sections than in negative stain preparations. 相似文献
155.
目的:探讨非抗生素治疗手段在泛耐药菌珠所致老年重症肺部感染疾病治疗中的可行性。方法选取2010年4月-2012年9月机械通气患者81例,根据治疗方案不同将患者分为A组36例及B组45例。 A组治疗措施主要为应用胸腺肽类药物、丙种球蛋白免疫调节剂和血必净,每天进行1~2次的气管镜吸引及灌洗等。 B组在A组的基础上继续给予经验性抗生素治疗。比较2组APACHEⅡ评分、白细胞数、体温及耐药性。结果 A组患者致病菌的耐药性由原来的100.0%广泛耐药特性降至55.2%,而B组患者致病菌耐药性未见明显改变;而白细胞含量经过非抗生素处理干预治疗后的A组白细胞数量有所下降,且与治疗前比较差异有统计学意义(P<0.05)。治疗1个月,A组死亡2例,病死率为5.6%,而B组死亡10例,病死率为22.2%,差异有统计学意义(P<0.01)。结论非抗生素治疗可使患者致病菌耐药性下降,降低病死率,具有可行性。 相似文献
156.
J. Fayard S. Collardeau Y. Bertrand M.-P. Cordier C. Malcus R. Dubois P.-Y. Mure G. de Saint Basile T. Louazon B. Rohmer A. Lachaux R. Duclaux N. Peretti 《Archives de pédiatrie》2018,25(5):334-339
TTC7A mutations cause multiple neonatal intestinal atresias with early inflammatory bowel disease and severe combined immunodeficiency. There are no treatment protocols for this rare disease. Two new cases are described for which radical early treatment measures – total enterectomy, home parenteral nutrition, immunoglobulin therapy and intravenous antibiotic prophylaxis – have allowed both patients to develop optimally. 相似文献
157.
《Expert Review of Clinical Immunology》2013,9(6):503-505
Evaluation of: Laharie D, Bourreille A, Branche J et al.; Groupe d’Etudes Thérapeutiques des Affections Inflammatoires Digestives. Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. Lancet 380(9857), 1909–1915 (2012).Severe active refractory ulcerative colitis is a potentially life-threatening disease. The introduction of intensive steroid treatment and early surgery has reduced mortality in recent years. Ciclosporin and infliximab are effective rescue therapies in steroid refractory colitis. A head-to-head study proposed by Laharie et al. failed to demonstrate the superiority of ciclosporin but confirmed the efficacy and safety of infliximab to control active disease and to maintain remission. 相似文献
158.
《Expert review of anti-infective therapy》2013,11(4):593-600
Defining the severity of an infection can play a central role for a correct therapeutic choice, avoiding inadequate antimicrobial treatments. Severe bacterial infections are, in fact, characterized by high morbidity and mortality rates so that the appropriateness of therapy can have a profound clinical impact. Indeed, initial inappropriate empirical therapies, and the further need to modify them, substantially increase the mortality risk. Several strategies have been suggested to improve the clinical outcome of patients affected by severe bacterial infections, such as the use of guidelines, use of antibiotics in combination, de-escalation therapy, cycling therapy and the use of infectious disease specialist consultation. A closer collaboration between the medical staff in the wards and infectious disease specialists can possibly bridge the gap between different strategies and individual needs of the patient, thereby improving the decision-making process. 相似文献
159.
Caroline M. Hsu Daniel E. Weiner Gideon Aweh Dana C. Miskulin Harold J. Manley Carol Stewart Vlad Ladik John Hosford Edward C. Lacson Douglas S. Johnson Eduardo Lacson 《American journal of kidney diseases》2021,77(5):748-756.e1
- Download : Download high-res image (408KB)
- Download : Download full-size image
160.